Researchers from the Wellcome-MRC Institute of Metabolic Science at the University of Cambridge in the United Kingdom developed an artificial pancreas that they tested on patients with type 2 diabetes who were in end-stage renal failure and on dialysis. After the artificial pancreas worked well with this group, the researchers wanted to learn whether it… Continue reading Type 2 diabetes: Artificial pancreas may soon be an option
The number of people with Alzheimer’s disease is increasing rapidly. Some hail human monoclonal antibodies that clear beta-amyloid deposits from the brain as the first disease-modifying treatments for the condition. However, they are not without controversy — the Food and Drug Administration approved aducanumab despite a lack of evidence for its efficacy and concerns about… Continue reading Progress and controversy in Alzheimer’s research: Aducanumab’s FDA approval
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!